Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
cases increased » levels increased (Expand Search), cycles increases (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
Showing 1,481 - 1,500 results of 25,269 for search '(( significant ((force decrease) OR (cases increased)) ) OR ( significant decrease decrease ))', query time: 0.74s Refine Results
  1. 1481
    Mean values (± standard deviation) of electrolyte concentrations before and after CWI.

    Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1482
    Mean values (± standard deviation) of lipid profile parameters before and after CWI.

    Mean values (± standard deviation) of lipid profile parameters before and after CWI. by Aneta Teległów (9570190)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1483
    The effect of CWI on blood levels of (A) creatine kinase (CK); (B) CK-muscle brain (CK-MB) and (C) lactate dehydrogenase (LDH) in young healthy males.

    The effect of CWI on blood levels of (A) creatine kinase (CK); (B) CK-muscle brain (CK-MB) and (C) lactate dehydrogenase (LDH) in young healthy males. by Aneta Teległów (9570190)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1484
    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases.

    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1485
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1486
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1487
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1488
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1489
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1490
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1491
    MEVA genes replicated in UKB and AoU (n = 23). Genes are annotated with the MEVA p-value and rank (1 = most significant) in UKB and AoU, and sorted by the number of PubMed co-mentions between the gene and “Type 2 Diabetes”.

    MEVA genes replicated in UKB and AoU (n = 23). Genes are annotated with the MEVA p-value and rank (1 = most significant) in UKB and AoU, and sorted by the number of PubMed co-menti... by Kevin Wilhelm (9268060)

    Published 2025
    Save to List
    Saved in:
  12. 1492
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  13. 1493
    Effects of BM-MSCs on ROS generation in DCS rats.

    Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1494
    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation.

    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1495
    Isotype control overlays.

    Isotype control overlays. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1496
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1497
    Original uncropped blot.

    Original uncropped blot. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1498
    Characterization of BM-MSC.

    Characterization of BM-MSC. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1499
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1500
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: